Crystal Adam bought TNGX
April 15, 2026 · Form 4 insider transaction
Crystal Adam bought 38,460 shares of Tango Therapeutics, Inc. at $5.20 per share, a transaction worth $200.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
38,460
Price
$5.20
Total value
$200.0K
InsiderCrystal Adam
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 15, 2026
Filing dateApril 16, 2026
Shares owned after151,082
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.